ATE294388T1 - Modulatoren der cytosin-5-methyl-transferase und verfahren zu ihrer verwendung - Google Patents

Modulatoren der cytosin-5-methyl-transferase und verfahren zu ihrer verwendung

Info

Publication number
ATE294388T1
ATE294388T1 AT98930207T AT98930207T ATE294388T1 AT E294388 T1 ATE294388 T1 AT E294388T1 AT 98930207 T AT98930207 T AT 98930207T AT 98930207 T AT98930207 T AT 98930207T AT E294388 T1 ATE294388 T1 AT E294388T1
Authority
AT
Austria
Prior art keywords
dna
synthetic oligonucleotide
inhibiting
methylation
disclosed
Prior art date
Application number
AT98930207T
Other languages
English (en)
Inventor
Norbert O Reich
James Flynn
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE294388T1 publication Critical patent/ATE294388T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/13—Decoys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C12N2310/334—Modified C

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT98930207T 1997-08-29 1998-06-12 Modulatoren der cytosin-5-methyl-transferase und verfahren zu ihrer verwendung ATE294388T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5741197P 1997-08-29 1997-08-29
PCT/US1998/012351 WO1999012027A1 (en) 1997-08-29 1998-06-12 Modulators of dna cytosine-5 methyltransferase and methods for use thereof

Publications (1)

Publication Number Publication Date
ATE294388T1 true ATE294388T1 (de) 2005-05-15

Family

ID=22010427

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98930207T ATE294388T1 (de) 1997-08-29 1998-06-12 Modulatoren der cytosin-5-methyl-transferase und verfahren zu ihrer verwendung

Country Status (6)

Country Link
EP (1) EP1018003B1 (de)
JP (1) JP2001514862A (de)
AT (1) ATE294388T1 (de)
CA (1) CA2300354A1 (de)
DE (1) DE69829984D1 (de)
WO (1) WO1999012027A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790955B1 (fr) 1999-03-19 2003-01-17 Assist Publ Hopitaux De Paris Utilisation d'oligonucleotides stabilises comme principe actif antitumoral
US6890736B1 (en) 2002-09-20 2005-05-10 Immunex Corporation Methods for producing proteins in cultured cells
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
WO2011018435A1 (en) 2009-08-10 2011-02-17 Institut Curie Method for predicting the sensitivity of a tumor to an epigenetic treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578716A (en) * 1993-12-01 1996-11-26 Mcgill University DNA methyltransferase antisense oligonucleotides
US5652105A (en) * 1995-07-28 1997-07-29 Health Research, Inc. Substrate for detection of mammalian 5-C-DNA methyltransferase
CA2256305A1 (en) * 1996-05-22 1997-11-27 Mcgill University Specific inhibitors of dna methyltransferase enzyme

Also Published As

Publication number Publication date
EP1018003A1 (de) 2000-07-12
DE69829984D1 (de) 2005-06-02
EP1018003A4 (de) 2002-04-17
JP2001514862A (ja) 2001-09-18
WO1999012027A1 (en) 1999-03-11
CA2300354A1 (en) 1999-03-11
EP1018003B1 (de) 2005-04-27

Similar Documents

Publication Publication Date Title
Balada et al. DNA methylation and systemic lupus erythematosus
Kufe et al. 5-Fluoro-2'-deoxyuridine incorporation in L1210 DNA.
Guo et al. Neuronal activity modifies the DNA methylation landscape in the adult brain
Datta et al. Biochemical fractionation reveals association of DNA methyltransferase (Dnmt) 3b with Dnmt1 and that of Dnmt 3a with a histone H3 methyltransferase and Hdac1
Machwe et al. The Werner and Bloom syndrome proteins catalyze regression of a model replication fork
Reddy et al. Nucleotide sequence of nucleolar U3B RNA.
ATE311884T1 (de) Cyclin-abhängige-kinase inhibierende purinderivate
ATE272596T1 (de) System und verfahren zum design von arzneimitteln,das auf einer struktur basiert und das eine genaue vorhersage der freien bindungsenergie ermöglicht
ATE213019T1 (de) Chimäre oligomere mit einer rns- spaltungsaktivität
Hascher et al. DNA methyltransferase inhibition reverses epigenetically embedded phenotypes in lung cancer preferentially affecting polycomb target genes
ATE244506T1 (de) Oligonukleotidmodulation der expression von multiwirkstoff-resistenz -assoziiertem protein
Neumeister et al. Senescence and epigenetic dysregulation in cancer
AU3208200A (en) A novel method for designing protein kinase inhibitors
Song et al. Are there specific readers of oxidized 5‐methylcytosine bases?
Flynn et al. Murine DNA (cytosine-5-)-methyltransferase: steady-state and substrate trapping analyses of the kinetic mechanism
DE69931029D1 (de) Optimierte antisense oligonukleotide komplementär zu dna-methyltransferase sequenzen
DK0731835T3 (da) Antisense-oligonukleotider med tumorigenicitetshæmmende virkning
Zardo et al. Does poly (ADP-ribosyl) ation regulate the DNA methylation pattern?
Roberts et al. Recurrent noncoding mutations in skin cancers: UV damage susceptibility or repair inhibition as primary driver?
Ishchenko et al. Thermodynamic, kinetic, and structural basis for recognition and repair of 8-oxoguanine in DNA by Fpg protein from Escherichia coli
Guschina et al. Recognition of specific and nonspecific DNA by human lactoferrin
Svedružić et al. Mechanism of allosteric regulation of Dnmt1's processivity
Duran-Ferrer et al. Epigenomic characterization of lymphoid neoplasms
Wang et al. DNA methylation determines the regulation of pregnane X receptor on CYP3A4 expression
Kulis et al. Integrative epigenomics in chronic lymphocytic leukaemia: Biological insights and clinical applications

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties